Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of cariprazine in schizophrenia extension study
NCT00839852Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- May 2009
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of cariprazine in schizophrenia, sponsored by Forest Laboratories. Started May 2009; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00839852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839852.